September 18, 2018—An international team of researchers has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice. In a study published this week in mBio, an open-access journal of the American Society for Microbiology, the team shows that a live, attenuated version of the Zika...